Oramed Pharmaceuticals (ORMP) Change in Accured Expenses (2016 - 2026)
Oramed Pharmaceuticals (ORMP) reported Change in Accured Expenses of $1000.0 for Q1 2026, up 100.54% on a YoY basis from $498.65 in Q1 2025, and up 101.47% quarter-over-quarter from -$68000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Change in Accured Expenses (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Change in Accured Expenses for 11 years, with the latest figure at $1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 100.54% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $126000.0 (down 73.02% YoY), and the FY2025 full-year result was -$60000.0, down 328.57% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $1000.0, up from -$68000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $3.1 million in Q3 2024, with the low at -$3.1 million in Q4 2024.
- Historically, Change in Accured Expenses has averaged -$4571.4 across 5 years, with a median of $1000.0 in 2023.
- The largest YoY upside for Change in Accured Expenses was 66200.0% in 2024 against a maximum downside of 311100.0% in 2024.
- Oramed Pharmaceuticals' Change in Accured Expenses stood at $37000.0 in 2022, then sank by 97.3% to $1000.0 in 2023, then plunged by 311100.0% to -$3.1 million in 2024, then soared by 97.81% to -$68000.0 in 2025, then jumped by 101.47% to $1000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $1000.0 (Q1 2026), -$68000.0 (Q4 2025), and $68000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | -185,000.00 |
| Mar 31, 2025 | -185,000.00 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Mar 31, 2024 | -666,000.00 |
| Mar 31, 2024 | -666,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |